Actos has become one of the most popular treatments for type 2 diabetes melli
tus. Now the FDA is warning of a link between Actos and bladder cancer. A recent study showed that the risk increases by 40% after 12 months on the drug. That risk is significant enough that the use of the drug has been suspended